Menopause | Medscape Menopause | Medscape
Review in-depth clinical information, latest medical news, and guidelines on menopause and perimenopause, including managing hot flash symptoms and hormone therapy. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 17, 2019 Category: Consumer Health News Tags: Resource Center Source Type: news

Prevalence of Knee OA Lower With Menopausal Hormone Therapy
THURSDAY, Jan. 17, 2019 -- For postmenopausal women, the prevalence of knee osteoarthritis is lower with menopausal hormone therapy (MHT) use, according to a study published online Dec. 21 in Menopause. Jae Hyun Jung, M.D., Ph.D., from the Korea... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 17, 2019 Category: Pharmaceuticals Source Type: news

Menopausal Hormone Tx Use Down Post-WHI Recommendations
MONDAY, Jan. 14, 2019 -- The Women's Health Initiative (WHI) recommendations for menopausal hormone therapy (MHT) use issued in 2002 have been widely adopted, according to a study published online Dec. 21 in Menopause. Sybil L. Crawford, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 14, 2019 Category: Pharmaceuticals Source Type: news

Jan 11 2019 This Week in Cardiology Jan 11 2019 This Week in Cardiology
Appropriate use criteria for imaging, HRRP efficacy, medical marijuana, radiation exposure in the cath lab, and hormone therapy are the topics discussed this week ’ s podcast.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 11, 2019 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Hormone Therapy May Protect Against Knee Osteoarthritis Hormone Therapy May Protect Against Knee Osteoarthritis
Postmenopausal women taking hormone therapy were significantly less likely to develop symptomatic knee osteoarthritis compared with those who did not take hormone therapy, a large study has found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 11, 2019 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Hormone therapy may lower the risk of knee osteoarthritis
Research, published inMenopause, suggests that women who receive hormone therapy have a lower risk of developing osteoarthritis.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 10, 2019 Category: Endocrinology Source Type: news

Hormone therapy may be best defense against knee osteoarthritis
(The North American Menopause Society (NAMS)) There is an ongoing debate regarding the relationship between knee osteoarthritis and hormone therapy (HT), with small-scale studies providing mixed results. A new large-scale study from Korea shows that women receiving HT had a significantly lower prevalence of symptomatic knee osteoarthritis compared with women who did not take hormones. Study results are published online in Menopause, the journal of The North American Menopause Society (NAMS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 8, 2019 Category: International Medicine & Public Health Source Type: news

Gender-Affirming Hormone Therapy Doesn't Lower BMD in Adults Gender-Affirming Hormone Therapy Doesn't Lower BMD in Adults
Gender-affirming hormone treatment (HT) does not weaken bones in adults with long-term use, according to a new study in hundreds of transgender men and women.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 5, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Gender-Affirming Hormone Therapy and the Risk of Tumors Gender-Affirming Hormone Therapy and the Risk of Tumors
Are transgender individuals receiving gender-affirming hormone therapy at a greater risk for developing hormone-dependent tumors?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 24, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Study claims some fertility treatments raise the risk of autism in children
(Natural News) For couples who cannot have children, fertility treatments could be heaven-sent. But according to a study by American and Swedish researchers, the said treatments may not be as seamless as they are made out to be, with progesterone hormone therapy, in particular, causing a rise in children who have autism. The researchers from... (Source: NaturalNews.com)
Source: NaturalNews.com - December 16, 2018 Category: Consumer Health News Source Type: news

Lower-Dose Tamoxifen Works As Well As High-Dose
New research shows that a lower dose of the hormone therapy Tamoxifen is as effective as the higher dose treatment in helping to prevent breast cancer from returning and guarding against new cancers in women who had high-risk breast tissue. (Source: WebMD Health)
Source: WebMD Health - December 6, 2018 Category: Consumer Health News Source Type: news

Targeted Drug Plus Hormone Therapy Stops Tumor Growth In Patients With Early Breast Cancer
A targeted cancer drug added to hormone therapy has been shown to stunt cancer growth in women with newly diagnosed breast cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 6, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: NASDAQ:PFE Source Type: news

Circulating tumor cell count could help choose treatment for metastatic breast cancer patients
(American Association for Cancer Research) Circulating tumor-cell (CTC) count could be used to choose hormone therapy or chemotherapy as frontline treatment for patients with estrogen receptor-positive (ER+), HER2-negative (HER2-) metastatic breast cancer, according to data from the phase III STIC CTC clinical trial presented at the 2018 San Antonio Breast Cancer Symposium. In the case of discrepancy between CTC count-based treatment choice and physician's choice of treatment, frontline chemotherapy was associated with a significant gain in overall survival. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Post-Op Radiation Plus Hormone Therapy May Boost Aggressive Prostate Cancer Outcomes Post-Op Radiation Plus Hormone Therapy May Boost Aggressive Prostate Cancer Outcomes
In patients with aggressive (Gleason score 9-10) prostate cancer, adjuvant radiation/hormone combination therapy before recurrence may improve survival, researchers say.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - November 27, 2018 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Surgery & combination therapy optimizes results in aggressive prostate cancer management
(Brigham and Women's Hospital) Results published today in JAMA Oncology suggest post-operative radiation and hormone therapy, before cancer recurrence, as a new prostate cancer treatment option for men with a Gleason Score of 9 or 10. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2018 Category: Cancer & Oncology Source Type: news

Desert ginseng found to protect against premature ovarian failure in menopausal women, usually caused by medical treatment
(Natural News) Menopause is a natural event in the life of a woman in which the reproductive system starts to “shut down,” when the menstruation cycle ceases. Because of the side effects that come with menopause, treatments such as hormone therapy have been created (but they also come with side effects). Likewise, premature ovarian failure... (Source: NaturalNews.com)
Source: NaturalNews.com - November 13, 2018 Category: Consumer Health News Source Type: news

Coverage of hormonal breast cancer therapies increased in states that expanded Medicaid
(American Association for Cancer Research) An evaluation of breast cancer patients enrolled in Medicaid showed that states that expanded Medicaid during 2011 to 2017 had a 27 percent increase in prescriptions for hormonal therapy medications compared to states that did not expand Medicaid during the same period. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 2, 2018 Category: Cancer & Oncology Source Type: news

U.S. FDA Approves TherapeuticsMD's Menopause Drug U.S. FDA Approves TherapeuticsMD's Menopause Drug
The U.S. Food and Drug Administration (FDA) approved TherapeuticsMD's oral hormone therapy for menopause symptoms such as hot flashes, sleep disturbances and night sweats, the company said on Monday.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 29, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

FDA approves Boca Raton company's treatment for hot flashes from menopause
The U.S. Food and Drug Administration has approved a hormone therapy designed by a Boca Raton-based company to treat hot flashes for women going through menopause. Bijuva is expected to be available in pharmacies in the second quarter of 2019, TherapeuticsMD Inc. announced Monday. Earlier this year, the FDA approved its insert to treat vulvar and vaginal atrophy (VVA) and dyspareunia, or vaginal pain during sex caused by menopause, which was the company's (N asdaq: TXMD) first market-approved product. "This… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 29, 2018 Category: Biotechnology Authors: Emon Reiser Source Type: news

FDA approves TherapeuticsMD's menopause drug
The U.S. Food and Drug Administration (FDA) approved TherapeuticsMD's oral hormone therapy for menopause symptoms such as hot flashes, sleep disturbances and night sweats, the company said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - October 29, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

One size doesn ’t fit all, when using hormone therapy to treat endometriosis
The effectiveness of hormonal endometriosis therapy depends on whether a woman ’s endometriotic lesions have the progesterone receptor present. (Source: Yale Science and Health News)
Source: Yale Science and Health News - October 25, 2018 Category: Universities & Medical Training Source Type: news

One size doesn't fit all, when using hormone therapy to treat endometriosis
(Yale University) Endometriosis -- a condition caused by uterine tissue growing outside of the organ -- affects 10 percent of reproductive-aged women, whom it causes chronic pain that is significant and debilitating. The standard first-line treatment for all women with endometriosis is hormonal, specifically progestin-based, therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 25, 2018 Category: International Medicine & Public Health Source Type: news

Palbociclib and hormonal therapy may extend survival in advanced breast cancer patients
The drug palbociclib when combined with hormonal therapy extends the survival of patients with advanced breast cancer, according to research published in theNew England Journal of Medicine.The Guardian (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 22, 2018 Category: Endocrinology Source Type: news

Radiation and hormone therapy may extend survival in prostate cancer patients
Research, published inThe Lancet, suggests that radiation therapy combined with standard hormonal therapy can extend the survival in patients with locally spread prostate cancer. News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 22, 2018 Category: Endocrinology Source Type: news

'Treatment may extend advanced breast cancer survival'
Combining a drug with hormone therapy may extend the lives of some women with advanced breast cancer. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 22, 2018 Category: Consumer Health News Source Type: news

Zoledronic acid improves disease-free survival in premenopausal HR+ early breast cancer
(European Society for Medical Oncology) Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases disease-free survival compared to tamoxifen in premenopausal women with hormone receptor positive (HR+) early breast cancer, according to results reported at ESMO 2018 Congress in Munich. It is the first study to assess this specific combination in premenopausal breast cancer and adds to previous observations with zoledronic acid and anastrozole in premenopausal women receiving ovarian suppression. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 22, 2018 Category: Cancer & Oncology Source Type: news

Pelvic lymph node radiation provides significant benefit for prostate cancer patients
(American Society for Radiation Oncology) The first report of a large international clinical trial shows that, for men who show signs of prostate cancer after surgical removal of their prostates, extending radiation therapy to the pelvic lymph nodes combined with adding short-term hormone therapy to standard treatment can extend the amount of time before their cancer spreads. Findings will presented in a news briefing today at 12 p.m. from the American Society for Radiation Oncology (ASTRO) Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 22, 2018 Category: Cancer & Oncology Source Type: news

World Menopause Day
18 October 2018   is World Menopause Day and October is World Menopause Month.Cochrane Gynaecology and Fertility Group has published multiple reviews assessing the effectiveness and safety of interventions in menopausal women, including peri and postmenopausal women. To celebrate World Menopause Day we have collated a special selection of reviews investigating various treatments  for menopausal symptoms such as hormone therapy, tibolone, relaxation, exercise, and alternative therapy.Black cohosh (Cimicifuga spp.) for menopausal symptomsDehydroepiandrosterone for women in the peri- or postmenopausal phaseHormone t...
Source: Cochrane News and Events - October 18, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

One in six premenopausal early breast cancer patients do not adhere to hormonal therapy
(European Society for Medical Oncology) Nearly one in six premenopausal women being treated for early stage breast cancer do not adhere adequately to tamoxifen therapy after one year of treatment, potentially putting themselves at increased risk of recurrence and reduced survival, a French prospective study reports at ESMO 2018. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 18, 2018 Category: Cancer & Oncology Source Type: news

Hormone Therapy Not Beneficial in Subclinical Hypothyroidism
FRIDAY, Oct. 12, 2018 -- Thyroid hormone therapy is not associated with improvements in general quality of life or thyroid-related symptoms in non-pregnant adults with subclinical hypothyroidism, according to a review published in the Oct. 2 issue... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 12, 2018 Category: Pharmaceuticals Source Type: news

Usually no benefit in treating subclinical hypothyroidism
Data do not support routine use of hormone therapy in adults with subclinical hypothyroidism Related items fromOnMedica Amiodarone: thyroid monitoring Hyperthyroidism: diagnosis and management First trimester exposure to antithyroid drugs linked with birth defects Update treatment guidelines for underactive thyroid, urge doctors (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 4, 2018 Category: UK Health Source Type: news

Are You Tall? Better Watch Out For Varicose Veins
(CNN) — In what researchers are calling “the largest genetic study ever performed” on varicose vein disease, a Stanford University School of Medicine study found a person’s height to be a significant risk factor for developing varicose veins. “We not only found an association between height and varicose veins, but the genetic studies we did showed a causal link,” said cardiologist and study author Dr. Nicholas Leeper, an associate professor of surgery and cardiovascular medicine at Stanford. “That suggests that the genes and pathways that drive human height are also likely to be ca...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 24, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Local TV Varicose Veins Source Type: news

Estrogen-alone Therapy and Invasive Breast Cancer Incidence Estrogen-alone Therapy and Invasive Breast Cancer Incidence
Studies have demonstrated increased breast cancer risk associated with postmenopausal hormone therapy, but does risk vary depending on dose, formulation, and route of delivery of estrogen-alone HT?Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 20, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Black women more likely to skip crucial breast cancer treatments
(Oxford University Press USA) A new study in the Journal of the National Cancer Institute finds that black women are more likely to skip hormone therapy treatments, also known as endocrine therapy, for breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 20, 2018 Category: Cancer & Oncology Source Type: news

The New Old Age: For Elderly Women with Breast Cancer, Surgery May Not Be the Best Option
Nursing home patients may be frail or have other diseases, leading some doctors to advise hormone therapy rather than operations. (Source: NYT Health)
Source: NYT Health - September 14, 2018 Category: Consumer Health News Authors: PAULA SPAN Tags: Mammography Breast Cancer Surgery and Surgeons Elderly Nursing Homes Dr. Mara Schonberg Source Type: news

Medical News Today: Why does hormone therapy worsen some prostate cancers?
Some prostate cancers resist androgen-targeting therapy and continue to spread because the treatment alters the environment of tumor cells, a study shows. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 6, 2018 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Adverse effects of hormone therapy in prostate cancers
Hormone therapy is not always beneficial for prostate cancer patients, according to a study published in theJournal of Clinical Investigation.MedicalXpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - September 5, 2018 Category: Endocrinology Source Type: news

Hormone therapy can make prostate cancer worse, study finds
(Cedars-Sinai Medical Center) Scientists at Cedars-Sinai have discovered how prostate cancer can sometimes withstand and outwit a standard hormone therapy, causing the cancer to spread. Their findings also point to a simple blood test that may help doctors predict when this type of hormone therapy resistance will occur. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 4, 2018 Category: International Medicine & Public Health Source Type: news

Online tool can predict breast cancer relapse after hormone therapy
The new online tool‘CTS5’ can be used to determine if a patient is at risk of their breast cancer returning following hormone therapy, according to research published in theJournal of Clinical Oncology.MedicalXpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 29, 2018 Category: Endocrinology Source Type: news

Online tool can predicts breast cancer relapse after hormone therapy
The new online tool‘CTS5’ can be used to determine if a patient is at risk of their breast cancer returning following hormone therapy, according to research published in theJournal of Clinical Oncology.MedicalXpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 29, 2018 Category: Endocrinology Source Type: news

Menopause hormone therapy is linked to microscopic colitis
Treating menopause symptoms with hormones is associated with microscopic colitis, according to results published in the JournalGastroenterology.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 29, 2018 Category: Endocrinology Source Type: news

New Online Tool Aids Decisions on Breast Cancer Endocrine Tx New Online Tool Aids Decisions on Breast Cancer Endocrine Tx
A simple online risk tool to help clinicians decide whether women with hormone receptor-positive breast cancer should continue hormone therapy after 5 years has been developed by UK researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 24, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Relieve migraine pain by balancing hormones with a healthy diet and exercise
(Natural News) The relationship between migraines and hormones is one that has led to many women receiving warnings against hormone therapy. Using oral contraceptives has long been believed to increase the risk of stroke among migraine sufferers. Yet according to a recent study from the Women’s Health Initiative (WHI), that may not be necessarily be... (Source: NaturalNews.com)
Source: NaturalNews.com - August 21, 2018 Category: Consumer Health News Source Type: news

Stopping HRT does not increase atherosclerosis
According to a study, published inMenopause, stopping low-dose hormone therapy in menopause does not lead to a rebound effect on the advancement of atherosclerosis.Medscape (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 1, 2018 Category: Endocrinology Source Type: news

Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers
This research article found patients who received CM were more likely to refuse additional conventional cancer treatment (surgery/chemo or radio or hormone therapy) and had higher risk of death. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 1, 2018 Category: Consumer Health News Source Type: news

Menopause hormone therapy and your heart
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - August 1, 2018 Category: Consumer Health News Source Type: news

Housecall: Menopause and hormone therapy
THIS WEEK'S TOP STORIES Hormone therapy: Is it right for you??? Hormone replacement therapy ? medications containing female hormones to replace the ones the body no longer makes after menopause ? is sometimes used to treat common menopausal symptoms, including hot flashes and vaginal discomfort. Hormone therapy also has been proven to prevent bone loss [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 30, 2018 Category: Databases & Libraries Source Type: news

Transgender Hormonal Therapy Might Interfere with PrEP
(MedPage Today) -- 13% decrease in tenofovir availability; unclear whether it compromises protection (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - July 26, 2018 Category: Endocrinology Source Type: news

A trans woman says a pharmacist refused to fill her hormone prescription
Hilde Hall says she went straight from her doctor's office in April to a CVS pharmacy in her Phoenix suburb, eager to fill her first hormone therapy prescription. (Source: CNN.com - Health)
Source: CNN.com - Health - July 20, 2018 Category: Consumer Health News Source Type: news

How Complementary Cancer Therapies Can Increase Risk of Early Death
People diagnosed with cancer have a multitude of treatment options, many of which are standard therapies that have been well-studied to improve their chances of surviving their disease or avoiding recurrence. But people are increasingly also folding in complementary medicine approaches — which include nutrients, herbal remedies and other so-called natural supplements — with their cancer treatment regimes. While these are not nearly as well-studied as conventional therapies like surgery, radiation and chemotherapy, many people rely on them because they believe they can improve their chances of surviving their ca...
Source: TIME: Health - July 19, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news